Vliv výše úhrady na výrobní cenu u vybraných léčivých přípravků částečně hrazených z veřejného zdravotního pojištění v ČR v letech 2012-2020

The bachelor's thesis deals with the analysis of reimbursements of selected medicinal products in the Czech Republic in the years 2012 to 2020. In connection with changes in reimbursements of medicinal products, it compares the reactions of manufacturers and states the effect of changes in reimbursement of medicinal products. The basic principles and mechanisms of determining price and reimbursement payment regulation are described. The reimbursements in all groups of selected medicinal products changed two to six times between 2012 and 2020. On average, reimbursements for selected medicinal products decreased by 61.45 % over the last 8 years. In the analysis of the price of medicinal products, I come to the conclusion that in the period of decline in reimbursement of a medicinal product, its price decreases. The reason for the fall in price is the business strategy of manufacturers and price competition. A very strong positive correlation was found between reimbursement and the price of the medicinal product. The average of the correlation coefficients for all 24 investigational medicinal products is 0.792. 18 of the 24 medicinal products have a correlation coefficient greater than 0.75. The decline in payments and, as a result, prices, has some advantages and disadvantages. The benefits include saving health insurance resources and cheaper medicines for patients. The disadvantages may be, due to very low prices in the Czech Republic, the re-export of medicines abroad, outages in the supply of medicines or a reduction in the income of pharmacies, which limits the availability of medicinal products.